StockData
Matinas BioPharma Holdings, Inc. logo

Matinas BioPharma Holdings, Inc. (MTNB) income statement

MTNBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.80−0.01 (-1.26%)

Close on Nov 20, 2026Market cap $11.75MP/E –Yield –

Matinas BioPharma Holdings, Inc. financial ratios

See a number that looks wrong?